Navigation Links
Simcere Pharmaceutical Group to Announce First Quarter 2008 Earnings on Tuesday, May 6, 2008
Date:4/15/2008

NANJING, China, April 15 /PRNewswire-FirstCall/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and innovative anti-cancer pharmaceuticals in the rapidly growing China market, announced today that it intends to release its 2008 first quarter results on Tuesday, May 6, 2008, before the market opens in the United States. Simcere's chief executive officer, Jinsheng Ren, and chief financial officer, Frank Zhigang Zhao, will host an earnings conference call to discuss the company's 2008 first quarter results on Tuesday, May 6, at 8 a.m. EDT (Tuesday, May 6, at 8 p.m. Beijing/Hong Kong time).

To access the conference call, please dial:

United States toll-free dial-in number: +1.866.510.0712

United States dial-in number: +1.617.597.5380

China toll-free dial-in number: 10.800.130.0399

Hong Kong dial-in number: +852.3002.1672

Please ask to be connected to Simcere's Q1 2008 Earnings Call and provide the following passcode: 95590725. Simcere will also broadcast a live audio webcast of the conference call. The broadcast will be available by visiting the "Investor Relations" section of the company's Web site at http://www.simcere.com.

Following the earnings conference call, an archive of the call will be available by dialing:

United States toll-free dial-in number: +1.888.286.8010

United States dial-in number: +1.617.801.6888

The passcode for replay participants is: 67719578. The telephone replay also will be archived on the "Investor Relations" section of the company's Web site at

SOURCE Simcere Pharmaceutical Group
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd.
2. Simcere Pharmaceutical Group Reports Third Quarter 2007 Results
3. Simcere Pharmaceutical Group to Announce Fourth Quarter 2007 Earnings on Tuesday, March 4, 2008
4. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2007 Results
5. Simcere Pharmaceutical Group Announces Participation in Brean Murray Carret & Co.s Fourth Investor Tour of China
6. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5
...governments who want to help smokers kick ‘butts’;... as graphic and as big as possible. The UN’s Worl...the second major cause of death in the world. It i... 10 adults worldwide, or about five million deaths...
...hreat of losing vision due to smoking will prove t...s cited by the British Journal of Opthalmology. A...ind, losing vision is considered more serious by s... like stroke and lung cancer associated with it. H...
...oday. But whether patients survive cancer seems to...fford to spend// on the drugs, according to a Cana...tion life-saving cancer treatment, and some Canadi... because of where they live,” said the Cancer Advo...
...itional Indian science of ayurveda have questioned...harmacy Ltd (KAPL) to Kerala// Ayurveda Ltd, sayin...chi-based KAPL has been a leading name in Kerala's...n it merged with the Mauritius-based Katra Health ...
Other Medicine News:Health News:Statutory Warnings on Cigarette Packs- Make It Bigger and Brighter, Say Researchers 2Health News:Call for a National 'Drugs Funding Program' for Cancer Treatment in Canada 2Health News:Ayurveda Firm's Name Change Irks Experts 2
(Date:10/8/2008)... /- Vical Incorporated (Nasdaq: VICL...new nonclinical data,demonstrating that the compan...e in DNA- and protein-based infectious disease vac...Rolland, Pharm.D., Ph.D., Vical,s,Senior Vice Pres...a today,Wednesday, October 8, at the World Vaccin...
(Date:10/7/2008)... /- McLaren Health Care and its Great...world,s leading medical,minds to share the latest ...ointestinal cancer treatments. The October 11th sy... by McLaren,s Sukamal Saha, M.D., an,award-winning...apping for,colorectal cancer has gained worldwide ...
(Date:10/7/2008)...al Presented at the Osteoarthritis Research Societ..., N.J., Oct. 7 /- Ferring Pharmaceuti...X Trial of Osteoarthritis of the,Knee, showing tha...re,non-avian high molecular weight form of intra-a...ntra-articular saline (IA-saline) for the relief,o...
(Date:10/7/2008).../- CEL-SCI Corporation,(NYS... a Material Transfer,Agreement (MTA) with the Nati...and the laboratory of Dr. Francesco M. Marincola, ...s to the tumor microenvironment,caused by CEL-SCI,...f of,the Infectious Disease and Immunogentics Sect...
Breaking Medicine Technology:Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3STERIS Corporation Announces Date of Fiscal 2008 Third Quarter Earnings Release and Conference Call 9642 1STERIS Corporation Announces Date of Fiscal 2008 Third Quarter Earnings Release and Conference Call 9642 2STERIS Corporation Announces Date of Fiscal 2008 Third Quarter Earnings Release and Conference Call 9642 3OMI Medical Imaging Inc and Affiliated Companies File Chapter 11 Reorganization 9640 1OMI Medical Imaging Inc and Affiliated Companies File Chapter 11 Reorganization 9640 2Bristol Myers Squibb to Announce Results for the Fourth Quarter and Full Year of 2007 on January 31 2616 1RSB Spine LLC Announces First Implantation of the InterPlate 28TM 29 L for the Lumbar Spine 2614 1RSB Spine LLC Announces First Implantation of the InterPlate 28TM 29 L for the Lumbar Spine 2614 2
... 08, 2007 /PRNewswire-FirstCall/ -- Vanda,Pharmace...rector of,the Henry Ford Sleep Disorders and Resea...esentation on recent Phase III clinical,trial resu...T2),receptor agonist, at SLEEP 2007, the 21st annu...cieties, (APSS). , The Vanda presentation will tak...
...RE)--Jun 7, 2007 - ApoCell, Inc. presented the,res...iversity of,Chicago and ApoCell at the 2007 annual...ogy (ASCO) held in Chicago in early June.,The stud...iomarker,assay technology provides reliable predic...the benefit of treating aggressive head,and neck c...
Other Medicine Technology:Vanda Pharmaceuticals To Present Data on VEC-162 at SLEEP 2007, the,Annual Meeting of the Associated Professional Sleep Societies 2ApoCell's Cancer Predictive Index Helps Oncologists Select the Most,Effective Targeted Drug Therapy 2
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: